Development of the next generation radiation therapy based on molecular imaging

基于分子成像的下一代放射治疗的发展

基本信息

  • 批准号:
    22591392
  • 负责人:
  • 金额:
    $ 2.83万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2010
  • 资助国家:
    日本
  • 起止时间:
    2010 至 2012
  • 项目状态:
    已结题

项目摘要

To visualize intratumoral hypoxic areas and their reoxygenation before and during fractionated radiation therapy (RT), 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) were performed. Ten patients, consisting of four head and neck cancers, four gastrointestinal cancers, one lung cancer, and one uterine cancer, were included. F-MISO PET/CT was performed twice before RT and during fractionated RT of approximately 20 Gy/10 fractions for eight of the 10 patients. F-MISO maximum standardized uptake values (SUVmax) of normal muscles and tumors were measured. The tumor-to-muscle (T/M) ratios of F-MISO SUVmax were also calculated. Mean SUVmax ± standard deviation (SD) of normal muscles was 1.25 ± 0.17, and SUVmax above the mean + 2 SD (≧1.60 SUV) was regarded as a hypoxic area. Nine of the 10 tumors had an F-MISO SUVmax of equal to or more than 1.60. All eight tumors examined twice showed a decrease in SUVmax, T/M ratio, or percentage of hypoxic volume (F-MISO ≧1.60) at approximately 20 Gy, indicating reoxygenation. In conclusion, accumulation of F-MISO of ≧1.60 SUV was regarded as an intratumoral hypoxic area in our F-MISO PET/CT system. Most human tumors (90%) in this small series had hypoxic areas before RT, although hypoxic volume was minimal (0.0-0.3%) for four of the 10 tumors. In addition, reoxygenation was observed in most tumors at two weeks of the fractionated RT.
为了可视化分离放射治疗(RT)之前和期间的肿瘤内低氧区域及其重氧,进行了18F-氟甲唑胺极性发射断层扫描和计算机断层扫描(F-MISO PET/CT)。包括十名患者,包括四个头颈癌,四种胃肠道癌,1例肺癌和一个子宫癌。在RT之前进行了两次F-MISO PET/CT,在10例患者中,有8例在分离RT的RT分数约为20 Gy/10个部分。测量了正常肌肉和肿瘤的F-MISO最大标准化摄取值(SUVMAX)。还计算了F-Miso Suvmax的肿瘤与肌肉(T/M)比。正常肌肉的平均SUVMAX±标准偏差(SD)为1.25±0.17,超过平均值 + 2 SD(≧1.60SUV)的SUVMAX被视为低氧区域。 10个肿瘤中有9个具有等于或大于1.60的F-MISO SUVMAX。两次检查的所有八个肿瘤均显示suvmax,T/M比或低氧体积的百分比(F-Miso≧1.60)约为20 Gy,表明重氧。总之,F-Miso≧1.60SUV的积累被认为是我们的F-Miso PET/CT系统中的肿瘤内低氧区域。在此小型系列中,大多数人类肿瘤(90%)在RT之前具有低氧区域,尽管在10个肿瘤中有四个低氧量最小(0.0-0.3%)。另外,在分离的RT的两周内,大多数肿瘤都观察到了氧化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A two-step adaptive Intensity modulated radiation therapy (IMRT) scheme for head and neck cancer
头颈癌的两步自适应调强放射治疗 (IMRT) 方案
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    藤田真由美;今留香織;遠藤悟史;荘司好美;山田滋;今井高志;Nishimura Y
  • 通讯作者:
    Nishimura Y
PET/CT による放射線治療計画
使用 PET/CT 制定放射治疗计划
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    立花和泉;西村恭昌;柴田徹;中松清志;金森修一;小池竜太;西川龍之;石川一樹;田村昌也;細野 眞
  • 通讯作者:
    細野 眞
Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey
  • DOI:
    10.1007/s10147-011-0254-y
  • 发表时间:
    2012-02-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Nishimura, Yasumasa;Koike, Ryuta;Tamamoto, Tetsuro
  • 通讯作者:
    Tamamoto, Tetsuro
A two-step method of IMRT for head and neck cancer
头颈癌 IMRT 的两步法
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takashi Imai;Atsuko Ishikawa;Tomo Suga;Yoshimi Shoji;Nishimura Y
  • 通讯作者:
    Nishimura Y
A prospective clinical trial on tumor hypoxia imaging with 18F-misonidazole (F-MISO) positron emission tomography (PET)
18F-米索硝唑 (F-MISO) 正电子发射断层扫描 (PET) 肿瘤缺氧成像的前瞻性临床试验
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tachibana I;Nishimura Y;Shibata T;Kanamori S;Nakamatsu K;Tamura M;Koike R;Nishikawa T;Ishikawa K. Hosono M
  • 通讯作者:
    Ishikawa K. Hosono M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMURA Yasumasa其他文献

NISHIMURA Yasumasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMURA Yasumasa', 18)}}的其他基金

Organ-specific tolerance doses in intensity-modulated radiation therapy for head and neck cancer
头颈癌调强放射治疗中器官特异性耐受剂量
  • 批准号:
    20K08009
  • 财政年份:
    2020
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Adaptive radiation therapy based on in-room CT image
基于室内CT图像的自适应放射治疗
  • 批准号:
    16K10406
  • 财政年份:
    2016
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
High precision radiation therapy based on intra-tumoral hypoxic imaging
基于瘤内缺氧成像的高精度放射治疗
  • 批准号:
    25461932
  • 财政年份:
    2013
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical studies on the simultaneous integrated boost method using intensity modulated radiotherapy (IMRT)
调强放射治疗(IMRT)同步整合增强法的临床研究
  • 批准号:
    17591300
  • 财政年份:
    2005
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of intensity modulated radiation therapy (IMRT) based on radiobiology
基于放射生物学的调强放射治疗(IMRT)的发展
  • 批准号:
    14570887
  • 财政年份:
    2002
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relationship between molecular pathology of tumors and radiobiological parameters
肿瘤分子病理学与放射生物学参数的关系
  • 批准号:
    11670921
  • 财政年份:
    1999
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimation of tumor proliferative activity according to expression of cell-cycle-related antigen and selection of fractionation schema in radiation therapy.
根据细胞周期相关抗原的表达和放射治疗中分割方案的选择来估计肿瘤增殖活性。
  • 批准号:
    08671025
  • 财政年份:
    1996
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

mRNA反式调控基因转录的机制及其生物学功能
  • 批准号:
    32330018
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
增材制造锌镁合金复合椎间融合器降解调控机制与生物学效应研究
  • 批准号:
    52301302
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
  • 批准号:
    82330057
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
秸秆还田下玉/豆间作系统的生物固氮效应及微生物学机制
  • 批准号:
    32301962
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
III-E型CRISPR-Cas系统的结构生物学及其应用研究
  • 批准号:
    32371276
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Development of physically and biologically conformal high-precision photon irradiation strategy tailored to the clinicopathological features of metastatic brain tumors
针对转移性脑肿瘤的临床病理特征开发物理和生物保形高精度光子照射策略
  • 批准号:
    21K07561
  • 财政年份:
    2021
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
脳腫瘍の集学的治療時に生じる認知機能障害と脳内毛細血管密度の解析
脑肿瘤多学科治疗过程中认知功能障碍及脑内毛细血管密度分析
  • 批准号:
    21K07609
  • 财政年份:
    2021
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
高い抗腫瘍効果と副作用軽減を同時に目指す新規放射線治療法
一种新的放射治疗方法,旨在同时实现高抗肿瘤疗效和减少副作用
  • 批准号:
    20K08003
  • 财政年份:
    2020
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of multi-target neutron capture therapy with multiple boron drugs for brain tumor
多种硼药物多靶点中子俘获治疗脑肿瘤的建立
  • 批准号:
    20H03797
  • 财政年份:
    2020
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of markerless lung tumor detection based on the deep learing for real-time tumor-tracking radiotherapy.
基于深度学习的实时肿瘤跟踪放疗的无标记肺肿瘤检测的发展。
  • 批准号:
    18K07753
  • 财政年份:
    2018
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了